A. Tripathi et al., Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: A total series of 67 cases, ALL ASTH P, 21(2), 2000, pp. 101-105
Stevens-Johnson syndrome (SJS) is a severe cutaneous eruption that can be a
life-threatening emergency. Previously, we have reported our favorable exp
erience in treating 54 patients with SJS with systemic corticosteroids. We
continued our prospective analysis of consecutive patients with SJS treated
with corticosteroids. Possible etiologic factors and clinical outcomes of
the patients are described All 13 patients improved with initiation of syst
emic corticosteroid therapy. There was no mortality or permanent sequelae a
ttributable to SJS. Drugs were the offending agents in all 13 cases. There
was one death unrelated to SJS. In conclusion, prompt treatment with system
ic corticosteroids reduces morbidity and improves outcome of SJS patients.
This analysis extends our series to 67 consecutive patients with SJS who we
re treated with corticosteroids and had a favorable outcome.